Organogenesis' Debt Round

Organogenesis raised a round of funding on May 22, 2017. Investors include Eastward Capital Partners.

Organogenesis provides advanced wound care products for bio-active wound healing and soft tissue regeneration. The portfolio includes FDA-approved Apligraf and Dermagraft, for bio-active wound healing…

Articles about Organogenesis' Debt Round: